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ABSTRACT
Purpose: Thermal dose-effect relations have demonstrated that clinical effectiveness of hyperthermia
would benefit from more controlled heating of the tumor. Hyperthermia treatment planning (HTP) is a
potent tool to study strategies enabling target conformal heating, but its accuracy is affected by
patient modeling approximations. Homogeneous phantoms models are being used that do not match
the body shape of patients in treatment position and often have unrealistic target volumes. As a conse-
quence, simulation accuracy is affected, and performance comparisons are difficult. The aim of this
study is to provide the first step toward standardization of HTP simulation studies in terms of patient
modeling by introducing the Erasmus Virtual Patient Repository (EVPR): a virtual patient model database.
Methods: Four patients with a tumor in the head and neck or the pelvis region were selected, and
corresponding models were created using a clinical segmentation procedure. Using the Erasmus
University Medical Center standard procedure, HTP was applied to these models and compared to
HTP for commonly used surrogate models.
Results: Although this study was aimed at presenting the EVPR database, our study illustrates that
there is a non-negligible difference in the predicted SAR patterns between patient models and homo-
geneous phantom-based surrogate models. We further demonstrate the difference between actual
and simplified target volumes being used today.
Conclusion: Our study describes the EVPR for the research community as a first step toward standard-
ization of hyperthermia simulation studies.
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1. Introduction
Clinical and biological studies have shown the benefit of
hyperthermia as an additive to radiotherapy and chemother-
apy [1–5]. Given the demonstrated thermal dose-effect rela-
tions, clinical effectiveness would greatly benefit from
achieving more controlled temperatures; especially in mild
hyperthermia where homogeneous and target conformal
heating in the range between 42 and 43 C is considered
optimal [6–10]. Temperature monitoring is currently per-
formed using invasive catheters and thus limited to a few
measurement points or not applied at all due to patient
discomfort. This makes it difficult to verify the three-
dimensional (3D) temperature distribution during treatment.
A promising approach to overcome these clinical challenges
is hyperthermia treatment planning (HTP), which offers
potential for pretreatment and real-time optimization of
heating settings, parametric studies and the design of new
applicators [11].
In HTP simulation studies, it is common practice to use
computer-aided design (CAD) models of healthy volunteers
and homogeneous phantoms with anatomical shapes
[12–19]. These models, while readily available, often are not
representative of the hyperthermia patient models in terms
of anatomy, posture and target shape. Hence, the results of
many studies may be biased due to the use of these surro-
gate models, but the true impact of this bias is unknown. In
addition to that, comparisons amongst different studies are
difficult and of questionable relevance because of the differ-
ent models being used.
HTP has been used to study several novel technologies,
such as antenna concepts [20–22], applicator designs [23–25]
and optimization approaches for real-time optimization of
treatment settings [26–29]. Such simulation studies are often
conducted using segmented anatomies of healthy humans
or simplified homogeneous anatomies [12,13,17–19,30,31].
Since the early ‘70s, researchers worked on developing 3D
human models with diverse levels of detail. The advent of
computerized tomography (CT) and magnetic resonance
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imaging (MRI) resulted in the development of several high-
resolution 3D segmented anatomies derived from data of
healthy volunteers [32–38]. Besides some value of these
models, they are based on healthy volunteers or simplified
homogeneous anatomies and lack specific features of hyper-
thermia patient models, such as body shape conforming to
the treatment positioning and clinician-delineated tumor vol-
ume. Despite the partially known impact of these approxima-
tions, a standard set of patient models intended for HTP
purposes is not available.
Numerous HTP simulation studies were unable to properly
capture relevant features of patient models in simplified sur-
rogate models. In [39], a layered phantom model was shown
to be unrepresentative of patient anatomies for clinical com-
parison purposes since the fat-muscle transitions were
unrealistic. Similarly, de Bruijne et al. [40] and Trujillo-Romero
et al. [41] have shown the non-negligible impact on the spe-
cific absorption rate (SAR) of using simplified anatomies as
opposed to patient models (including metallic parts).
Moreover, although there is no consensus on the optimal tis-
sue list for segmentation, Kok and coworkers [42] mentioned
that high dielectric contrast interfaces (bone, fat, muscle tis-
sue) have a significant influence on the predicted tempera-
ture distribution. All of these studies demonstrate that
homogeneous phantoms cannot be considered appropriate
surrogates for patient models. In addition, the presence of
an invading tumor may further affect simulation results.
Other items affecting simulation accuracy are the treat-
ment posture and the presence of a tumor volume. The 3D
segmented anatomies derived from healthy volunteers
[32–38] do not include an invading tumor. The non-negli-
gible impact of this has been demonstrated in a head and
neck tumor patient, where the predicted SAR distribution in
the tumor was overestimated due to the lack of a region
with tumor properties in the patient model [43]. In the case
of deep pelvic hyperthermia, it was shown that HTP results
are strongly affected by the combination of the tumor pos-
ition and the shape of the patient body [44,45]. Finally,
Paulides et al. [11] extracted the need for modeling setups
matching the clinical scenario, when aiming for hotspot pre-
vention in the development of novel HT applicators. Hence
posture and the presence of the tumor are also important to
take into account.
The aim of this study is to stimulate open research by cre-
ating a common ground for hyperthermia simulation studies
in terms of patient modeling. Models of representative
patients with different target locations and sizes and that
have been treated with hyperthermia were selected. Two
models were created based on patients suffering from a
tumor in the head and neck (named Alex, Murphy) and two
were created since they had a tumor in the pelvic region
(named Clarice, Will). These CAD models are stored in a
novel, openly accessible database called the Erasmus Virtual
Patient Repository (EVPR). For the selected models, we illus-
trate the impact of realistic patient modeling by comparing
the predicted SAR distributions for approximated models to
results for the EVPR database. To illustrate the impact of real-
istic target shape, we imported clinician-delineated targets
into corresponding locations in the two homogeneous phan-
tom CAD models. We then proceeded to compare HTP
results with those of approximated (spherical or elliptical) tar-
gets of the same volume. SAR-based HTP was performed for
all models in accordance with the clinical procedure at
Erasmus MC Cancer Institute [29].
2. Materials and methods
2.1. Patient models
Four patient CAD models were created using the clinical seg-
mentation procedure as follows. For head and neck patient
models, HTP is based on CT scans made for radiotherapy
treatment planning. However, deep pelvic HTP is based on
CT scans made in a tailored sling (PYREXAR Medical, Salt
Lake City, UT). As such, the patient models are generated in
the exact same position and with the same body shape as
during the hyperthermia treatment [46–48]. The 3D models
were created by delineating scans into normal tissues and
the target volume using a semi-automatic segmentation rou-
tine followed by a manual adjustment in software tool iSeg
(Zurich Medtech, Zurich, Switzerland) [46]. For each case, a
trained clinician identified the hyperthermia target volume
(HTV) starting from the clinical target volume (CTV) for radio-
therapy treatment and adding certain margins depending on
the specific case [49,50]. These models constitute the EVPR
database and are depicted in Figure 1 and details are
reported in Table 1.
The male head and neck patient model named Murphy is
based on a patient with an oropharynx tumor (35ml), and
the model named Alex is based on a patient with a more
challenging case of a deeper-seated nasopharynx tumor
(44ml). The Murphy model was treated after surgery and
therefore only includes the HTV and no CTV (no solid tumor
mass). The deep pelvic patient model named Clarice is based
on a female patient with a cervix tumor (120ml), and the
deep pelvic model named Will is based on a male patient
with a more challenging rectum tumor having irregular con-
tours and a large volume (430ml). Note that for both
Clarice and Will the HTV coincides with the CTV from radio-
therapy planning. Density and electromagnetic properties at
different applicator operating frequencies are reported in
Table 2.
2.1.1. Representativeness of adopted 3D patient models
The EVPR database models were chosen to represent the
patient population regularly treated, taking into account the
experience of our group in HTP. We are aware that this data-
set should be the beginning of an actual patient model’s
repository that covers all of the most important variations in
patient and HTV characteristics. For the head and neck mod-
els, we considered both a model including a solid tumor
mass, Alex model, and a model which does not include it,
Murphy model. The Murphy model case is a less common
but realistic case. Its target constitutes multiple tissues that
are at high risk after the gross tumor was removed by sur-
gery. Furthermore, Alex includes one of the most challenging
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target volumes: a deep-seated nasopharynx tumor, shown in
Figure 2. On the other hand, stands the Murphy model,
which includes a target volume and location that is easier to
heat, but is challenging due to the presence of metallic teeth
implants that can cause local SAR hotspots. Similar reasoning
drove the selection of the deep pelvic models. Clarice and
Figure 1. The Erasmus Virtual Patient Repository: Alex, Murphy, Clarice and Will CAD models.
Table 1. Anatomical details of the patient models included in the
EVPR database.
Model/info Tumor location HTV volume
Murphy Oropharynx 35ml
Alex Nasopharynx 44ml
Clarice Cervix 120ml
Will Rectum 430ml
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Will exhibit different fat percentages and body sizes, i.e.,
almost a twofold difference. As shown in Figure 2, Clarice is
representative of a target with a regular shape and volume
which is easier to heat, while Will includes a larger and
irregular target volume that surrounds the pubic bones.
2.1.2. 3D model volume anonymization for privacy
compliance
In order to comply with current privacy regulation and be
able to share the described patient models, no information
possibly identifying the single models of the EVPR database
can be shared [51]. To this end, anonymization of the 3D
voxel model was needed for both Alex and Murphy. A non-
isotropic volume expansion of the muscle tissue has been
added with the aim of covering the eyes. This added layer,
shown in Figure 1, hides the eye structures and shapes to
avoid any possible link to the individual. We verified that this
added layer did not affect the HTP metrics.
2.2. HTP workflow
The first step for HTP includes segmenting the 3D patient
models. The patient-specific models were imported into
Sim4Life (Zurich MedTech AG, Zurich, Switzerland) along
with the related 3D applicator model. The HYPERcollar3D,
operating at 434MHz, was used for the head and neck
patients [43] and the Pyrexar BSD2000 Sigma 60 applicator
(Pyrexar Medical Corp., Salt Lake City, UT), operating at
77MHz, [52,53] was used for the patients with a deep pelvic
tumor. Electromagnetic tissues properties for these frequen-
cies were assigned to each of the segmented tissues and are
presented in Table 2. The water bolus was modeled by a
water volume with relative permittivity of 80 and conductiv-
ity of 0.04 S/m for 434MHz and 0.003 S/m for 77MHz
between the patient and the applicator shell. The total field
was computed for a 1 V sinusoidal signal excitation and 20
periods of harmonic signal for each antenna at the operating
frequency. The electric field per antenna was normalized to
1 W radiated power and the cubic filtered SAR (cf-SAR) pat-
tern optimized using our Visualization Tool for
Electromagnetic Dosimetry and Optimization (VEDO) software
[29]. The optimization strategy implemented in VEDO aims at
maximizing the Target to Hotspot Quotient (THQ), which is
expressed as:
THQ ¼ <SAR>HTV
< SAR>hotspot
where < SAR>HTV is the average SAR within the target vol-
ume and < SAR>hotspot is the average SAR at the hot-spot,
which is defined as the cumulative 1% volume in all healthy
tissues with the highest SAR. Particle swarm optimization
scheme was used to maximize the THQ cost function. The
HTV was used as optimization target volume. A more
detailed description of HTP can be found in [29,50].
2.3. Comparison with realistic representative models
The EVPR database models were compared to realistic repre-
sentative modeling approaches, which are described below
Table 2. List of the electromagnetic properties at 434MHz and 77MHz and density of all tissues included in Will, Clarice, Alex and
Murphy CAD models [29].
Name Frequency (MHz) Relative permittivity Electrical conductivity (S/m) Density (kg/m3)
Bone 434 13.07 0.09 1908
77 16.00 0.06
Fat 434 11.59 0.08 911
77 13.20 0.07
Muscle 434 56.86 0.80 1090
77 69.30 0.69
Lung 434 23.58 0.38 394
Cerebrum 56.81 0.75 1045
Brain stem 55.11 1.04 1046
Myelum 35.03 0.45 1075
Sclera 57.37 1.01 1032
Lens 37.28 0.37 1076
Vitreous humor 68.99 1.53 1005
Cartilage 45.14 0.59 1100
Thyroid 61.32 0.88 1050
Optical nerve 35.03 0.45 1075
GTV 434 59.00 0.89 1050
77 69.00 0.70
Figure 2. Sagittal and transversal view of the Erasmus Virtual Patient Repository
CAD models enlightening the gross tumor volume (GTV) and/or the hyperther-
mia target volume (HTV) location within bone structures. In the case of
Murphy, the HTV, in pink, is reported as no solid GTV is present.
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and are inspired by the strategies commonly used in litera-
ture to mimic patient models. In the following investigation,
we considered simplified homogeneous anatomies including
ellipsoidal target volumes or clinician-delineated HTV. The
HTP quality parameters achieved for these surrogate models
were compared to those of the EVPR database.
The effect of the tissue distribution has been investigated
using homogenous models. We included two in-house devel-
oped patient modeling phantoms for deep pelvic and head
and neck tumors. Homogeneous electromagnetic properties
were assumed except for the HTV. The HENK phantom con-
sists of a human-shaped shell containing bone structure
resembling a human spine and pelvis embedded into homo-
genous dielectric material with permittivity equal to 69.3 and
conductivity 0.69 S/m at 77MHz [54]. The ADAM phantom,
‘Anthropomorphic Dosimetry head And neck Mannequin’,
was obtained as the average shape of 30 head and neck
patient models and it does not have any bone structures.
We used a relative permittivity of 41 and a conductivity of
0.50 S/m at 434MHz.
The impact of using an actual clinician-delineated HTV
was investigated by including both the actual HTV and an
ellipsoidal target volume within both ADAM and HENK.
These generic target volumes had the same volume of the
clinician-delineated HTV and have been places at the same
position of the clinician-delineated HTV. Note that the HTP
workflow was performed for each approximated model
(ADAN and HENK) and each target shape (HTV and approxi-
mated elliptical target) and compared to the EVPR data-
base models.
2.4. Evaluation metrics
In order to quantify the differences between the two patient
model approaches, we used two standard HTP SAR quality
metrics: THQ and target coverage. The THQ has been defined
in Section 2.2. The target coverage is defined as the percent-
age of the target volume which is above a certain percent-
age of the maximum SAR induced within the patient model.
We considered target coverage above 25% and 50% of the
maximum and we indicated these as TC25 and TC50,
respectively.
These metrics are currently used for clinical decision mak-
ing for head and neck, superficial and deep pelvic patients.
Canters et al. [55] used the predicted temperature parame-
ters as a basis for selecting a set of quality indicators and
optimization functions for deep pelvic hyperthermia, applied
with the BSD2000 Sigma 60 applicator also used here. Their
results showed the THQ as being most predictive for median
target temperature, T50. Earlier, a relation was found
between the target coverage of the TC25 and clinical out-
come for superficial hyperthermia [56]. Recently, for the case
of head and neck cancer treated with HYPERcollar3D, Bellizzi
et al. [57] identified TC50 as best temperature surrogate
related to median target temperature. Assessing differences
in terms of these quantities will reflect on predicted tem-
perature and hence on treatment outcome [58,59].
3. Results
3.1. Impact of the anonymization volume for Alex
and Murphy
The maximum difference in terms of SAR quality metrics was
found in target coverage and it deviates 1% for the not ano-
nymized vs. the anonymized volumes. Note that only
0.17% of the whole model volume was added. Figure 3
depicts two sagittal views of the normalized SAR distribution
induced in both not anonymized and anonymized Murphy
where the maximum qualitative difference was observed.
3.2. Impact of target modeling
Tables 3–6 report the SAR quality metrics obtained for the
EVPR database models compared to the homogeneous phan-
tom models including both simplistic and target volumes
delineated by clinicians. The SAR quality metrics achieved
with the EVPR database were compared to two different
Figure 3. Sagittal views of the normalized SAR distributions achieved when
performing HTP in Murphy’s before and after CAD model anonymization
through eyes structure morphing. The red arrows indicate the location of the
maximum difference in the SAR.
Table 3. SAR-based quality metrics for the Alex model (head and neck)
including a nasopharynx HTV compared to ADAM including the Alex’s naso-
pharynx HTV and a volume- and position-matched spherical target volume.
Model TC25 (%) TC50 (%) THQ (–)
ADAMþ generic target 100 100 1.14
ADAMþHTV 100 100 1.34
Alex 94 71 1.21
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modeling approaches with increasing complexity. While
Tables 3–6 report the SAR quality metric values, in the fol-
lowing we aimed at briefly report on the effect of using sim-
plistic modeling as opposed to patient modeling. Specifically,
comparing the EVPR database planning metrics with those
for the homogeneous phantoms (ADAM and HENK),
we found:
1. In case of a spherical/elliptical target, an average difference
of jDTC25j ¼ 21%, jDTC50j ¼ 57% and jDTHQj ¼ 0.16.
2. In the case of realistic target (HTV), an average differ-
ence jDTC25j ¼ 28%, jDTC50j ¼ 13% and jDTHQj ¼ 0.09.
where jDXj is equal to jX1 – X2j and X1 and X2 represent
the SAR quality metrics for the different cases.
For qualitative observations besides the SAR quality met-
rics, Figure 4 depicts both a transversal and a sagittal cross-
section of the normalized cf-SAR distributions induced in
Clarice and Alex as compared to the above-mentioned surro-
gate models. When comparing the power deposition pattern
achieved within ADAM and HENK as compared to the EVPR
database models, the focus location appears at the HTV loca-
tion, whereas the homogeneous tissue-mimicking-material
yields to a smooth and unrealistic distribution. Finally, the
tissue segmentation yields to different SAR distribution and
hence to different hot-spot locations (potentially, to organs
at risk or more sensitive areas) when comparing Ella or Duke
with the EVPR database models.
4. Discussion
This work shows the impact of modeling based on patient
anatomy segmentation and including clinician-delineated
HTVs for simulation guided research purposes. Our analysis
aimed at showing the differences of using surrogate models
with arbitrary shaped target volumes instead of patient
models. In our analyses, we used SAR quality parameters
that are used at Erasmus MC for clinical decision making dur-
ing hyperthermia treatments as they correlate to predicted
temperature for both deep [55] and head and neck hyper-
thermia [57].
From a qualitative point of view, Figure 4 suggests the
use of homogenous phantom modeling as first step in simu-
lation studies because of the good predictability and measur-
ability of SAR patterns into phantoms for quality assurance
purposes. However, these homogeneous phantom models
are not representative of patient models, as excessively
smooth and not realistic SAR patterns are observed.
Therefore, virtual studies should be based on patient-specific
modeling, as surrogate models inevitably lead to modeling
inaccuracies. Clinician-delineated target volumes and models
of patients in treatment position need to be used for in
simulation studies [44,45]. Hence, while simplistic modeling
might be useful first step in simulation-guided technology
development, final tests and conclusion should be drawn on
actual clinical models.
Although we focused our attention on SAR quality metrics
in our investigations, the findings are consistent in terms of
predicted temperature too, as was shown previously [55,57].
For the case of head and neck cancer treated with
HYPERcollar3D, Bellizzi et al. [57] demonstrated in a
Table 4. SAR-based quality metrics for the Murphy model (head and neck)
including an oropharynx HTV compared to ADAM including the Murphy’s oro-
pharynx HTV and a volume- and position-matched spherical target volume.
Model TC25 (%) TC50 (%) THQ (–)
ADAMþ generic target 97 64 0.68
ADAMþHTV 58 24 0.38
Murphy 46 16 0.36
Table 5. SAR-based quality metrics for the Clarice model (pelvis) including a
cervix HTV compared to HENK including Clarice’s cervix HTV and a volume-
and position-matched spherical target volume.
Model TC25 (%) TC50 (%) THQ (–)
HENKþ generic target 100 99 0.70
HENKþHTV 100 97 0.70
Clarice 81 0 0.48
Table 6. SAR-based quality metrics for the Will model (pelvis) including a cer-
vix HTV compared to HENK including Will’s cervix HTV and a volume- and
position-matched spherical target volume.
Model TC25 (%) TC50 (%) THQ (–)
HENKþ generic target 100 91 0.70
HENKþHTV 99 84 0.70
Will 85 39 0.71
Figure 4. Transversal view through the HTV mid-line (green contour) of the
SAR distributions predicted for the different patient model approximations and
Clarice and Alex from the Erasmus Virtual Patients Repository, respectively.
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simulation study that the TC50 is the optimal temperature
surrogate, which is correlated to median predicted target
temperature (T50). For the case of deep pelvic cancer treated
with the BSD2000 Sigma 60 applicator, Canters et al. [55] dis-
tinguished the THQ as most predictive for predicted T50.
According to these studies, the differences in the predicted
SAR quality indicators found in the proposed initial study,
would translate into a variation in median predicted HTV
temperature T50 greater than 0.75 C [58,59]. However, open
discussions are still ongoing regarding the impact of this on
clinical effectiveness. In this work, we have chosen not to
include temperature simulation, as SAR is usually the first
step of technology development as it is the more straightfor-
ward indicator of the field propagation and blood perfusion
mechanisms are not fully known. The open debate regarding
thermal properties as well as the unknown clinical outcome
of such improvements in predicted median temperature
could lead to different interpretations of the results.
The results of our work motivated us in sharing the EVPR
database with the hyperthermia community. Our work has
been mainly focused on the HTP. However, the provided
models can also be used for research into applications in
which a segmented patient anatomy is needed, like electrical
properties tomography (EPT) and focused ultrasound (FUS).
5. Conclusion
The aim of this study was to present and analyze the EVPR
database. This database includes four models of patients
undergoing hyperthermia for a tumor in the head and neck
(two) or pelvic region (two). The impact of anonymization
measures was found to be less than 1%-point for all HTP
metrics, i.e., TC25, TC50 and THQ. The impact of both a real-
istic posture and fat-muscle-bone discontinuities has been
shown by comparing homogenous phantom modeling with
patient models. The impact of using an actual delineated tar-
get (HTV) vs. an approximated target (sphere/ellipse) was
1–51% in TC25, 8–52% in TC50 and 0.01–0.32 in THQ.
The EVPR database forms a realistic database of models
from patients in treatment position for hyperthermia simula-
tion studies. These models allow to accelerate technology
developments by enabling faster and better comparisons
based on a common benchmark. Details for data transfer
agreement and downloads can be arranged via the corre-
sponding authors as well as through the European Society of
Hyperthermic Oncology (ESHO) webpage.
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